Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Finasteride may cause sexual side effects like erectile dysfunction, but they are reversible and affect less than 2% of men.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Hair loss drugs may cause sexual issues and infertility in men.

Finasteride 1-mg doesn't harm sperm or pregnancy chances.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Quick, selective detection of tadalafil and finasteride in human plasma developed.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

Doctors should prescribe cheaper, off-label medication and teach patients how to use it to save money ethically.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.